gilead glp-1 Got questions about medications and cancer? π¬ Join us for an informative session exploring how GLP-1 medications work, what current guidelines say for cancer patients and survivors, and what emerging research itβs the perfect companion for anyone using GLP HER Speaker Series: GLP 1
Description
Coskun T, Heise T, DeVries J et al (2022) Tirzepatide reduces appetite, energy intake and fat mass in people with type 2 diabetes
GLP-1 receptor agonists slow gastric emptying (though less so at microdoses)
Some users report that tirzepatide produces less constipation than semaglutide at equivalent efficacy levels, though head-to-head data is limited
doi: 10.1016/0014-5793(84)81114-X 17 CarlquistMMalettiMJrnvallHMuttV
Now the other thing I think is important is also getting a full thyroid panel
MultiStates team pulls from decades of expertise to help you effectively navigate and engage
